Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 31;24(12):1937-44.
doi: 10.1097/QAD.0b013e32833b3282.

Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda

Chelsea B Polis  1 , Maria J Wawer, Noah Kiwanuka, Oliver Laeyendecker, Joseph Kagaayi, Tom Lutalo, Fred Nalugoda, Godfrey Kigozi, David Serwadda, Ronald H Gray
Affiliations

Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda

Chelsea B Polis et al. AIDS. .

Abstract

Objective: To assess the association between hormonal contraceptive use and HIV progression.

Design: A retrospective analysis of 625 female HIV seroconverters from a Ugandan cohort study.

Methods: Multivariate Cox regression analyses incorporating time-varying hormonal contraceptive exposure were used to estimate the adjusted hazard ratios of death, and a composite outcome of AIDS or death, associated with hormonal contraceptive use. Sensitivity analyses included lagging hormonal contraceptive exposure, varying comparison groups, and separately assessing effects of oral and injectable contraceptives.

Results: A total of 27.5% of women reported ever using hormonal contraception. Of 625 women, 104 (16.6%) died and 291 (46.6%) progressed to AIDS or death during observation. Time-varying hormonal contraceptive use was not associated with an increased hazard of death as compared with nonuse of hormonal contraception (adjusted hazard ratio 0.76, 95% confidence interval 0.41-1.39, P = 0.37), and was associated with a significantly reduced hazard of progression to AIDS or death (adjusted hazard ratio 0.70, 95% confidence interval 0.50-0.97, P = 0.03). None of the sensitivity analyses suggested an adverse effect of hormonal contraception on HIV progression.

Conclusion: Hormonal contraceptive use was not associated with faster progression to death, and was associated with a reduced hazard of progression to the composite outcome of AIDS or death.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Survival by time-varying hormonal contraceptive (HC) use in Rakai, Uganda.
Fig. 2
Fig. 2
AIDS or death by time-varying hormonal contraceptive (HC) use in Rakai, Uganda.
See this image and copyright information in PMC

References

    1. Cates W., Jr Use of contraception by HIV-infected women. IPPF Med Bull. 2001;35:1–3.
    1. Shah I. Contraceptive use patterns in countries with different levels of HIV epidemic. J Acquir Immune Defic Syndr. 2005;38 (Suppl 1):S5–S6. - PubMed
    1. United Nations. World contraceptive use 2007. New York, USA: United Nations; 2008.
    1. Reynolds HW, Steiner MJ, Cates W., Jr Contraception’s proved potential to fight HIV. Sex Transm Infect. 2005;81:184–185. - PMC - PubMed
    1. Arrive E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, et al. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol. 2007;36:1009–1021. - PubMed

Publication types

Substances